453 related articles for article (PubMed ID: 16138892)
21. A rare case of amelanotic malignant melanoma in the oral region: Clinical investigation and immunohistochemical study.
Ohnishi Y; Watanabe M; Fujii T; Sunada N; Yoshimoto H; Kubo H; Wato M; Kakudo K
Oncol Lett; 2015 Dec; 10(6):3761-3764. PubMed ID: 26788204
[TBL] [Abstract][Full Text] [Related]
22. HMB-45 detection in adenocarcinomas.
Hancock C; Allen BC; Herrera GA
Arch Pathol Lab Med; 1991 Sep; 115(9):886-90. PubMed ID: 1718237
[TBL] [Abstract][Full Text] [Related]
23. [Monoclonal antibody HMB-45 in diagnosis of intra-ocular melanoma].
Rohrbach JM; Steuhl KP; Thanos S
Klin Monbl Augenheilkd; 1991 Oct; 199(4):274-7. PubMed ID: 1762354
[TBL] [Abstract][Full Text] [Related]
24. [Immunohistochemical markers for cytoplasmic antigens in acquired melanosis, malignant melanomas, and nevi of the conjunctiva].
Hitzer S; Bialasiewicz AA; Richard G
Klin Monbl Augenheilkd; 1998 Oct; 213(4):230-7. PubMed ID: 9848068
[TBL] [Abstract][Full Text] [Related]
25. Desmoplastic malignant melanoma of the oral mucosa. An underrecognized diagnostic pitfall.
Kilpatrick SE; White WL; Browne JD
Cancer; 1996 Aug; 78(3):383-9. PubMed ID: 8697380
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical evaluation of necrotic malignant melanomas.
Nonaka D; Laser J; Tucker R; Melamed J
Am J Clin Pathol; 2007 May; 127(5):787-91. PubMed ID: 17439838
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
Heegaard S; Jensen OA; Prause JU
Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
[TBL] [Abstract][Full Text] [Related]
28. Oral melanocytic lesions: differences in expression of HMB-45 and S-100 antigens in round and spindle cells of malignant and benign lesions.
Gazit D; Daniels TE
J Oral Pathol Med; 1994 Feb; 23(2):60-4. PubMed ID: 8164154
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation.
Sánchez J; Ramirez GA; Buendia AJ; Vilafranca M; Martinez CM; Altimira J; Navarro JA
Vet Pathol; 2007 Sep; 44(5):676-82. PubMed ID: 17846240
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical study of 40 cases of longitudinal melanonychia.
Theunis A; Richert B; Sass U; Lateur N; Sales F; André J
Am J Dermatopathol; 2011 Feb; 33(1):27-34. PubMed ID: 20940616
[TBL] [Abstract][Full Text] [Related]
31. An osteoid variant of cutaneous melanoma in a dog detected by S100 and melan a markers.
Maliver P; Estrada M; Lagadic M; Mialot M; Manin S; Fontaine JJ
J Vet Med A Physiol Pathol Clin Med; 2004 Dec; 51(9-10):413-5. PubMed ID: 15610483
[TBL] [Abstract][Full Text] [Related]
32. CD34 expression in primary cutaneous malignant melanoma: apropos of a case and review of the aberrant melanoma phenotype.
Breza TS; Magro CM
J Cutan Pathol; 2005 Nov; 32(10):685-9. PubMed ID: 16293181
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemistry of pigmented actinic keratoses, actinic keratoses, melanomas in situ and solar lentigines with Melan-A.
Helm K; Findeis-Hosey J
J Cutan Pathol; 2008 Oct; 35(10):931-4. PubMed ID: 18494818
[TBL] [Abstract][Full Text] [Related]
34. Melan A and S100 protein immunohistochemistry in feline melanomas: 48 cases.
Ramos-Vara JA; Miller MA; Johnson GC; Turnquist SE; Kreeger JM; Watson GL
Vet Pathol; 2002 Jan; 39(1):127-32. PubMed ID: 12102204
[TBL] [Abstract][Full Text] [Related]
35. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical diagnosis of canine oral amelanotic melanocytic neoplasms.
Smedley RC; Lamoureux J; Sledge DG; Kiupel M
Vet Pathol; 2011 Jan; 48(1):32-40. PubMed ID: 21078882
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
Chwirot BW; Kuźbicki Ł
Melanoma Res; 2007 Jun; 17(3):139-45. PubMed ID: 17505259
[TBL] [Abstract][Full Text] [Related]
38. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
[TBL] [Abstract][Full Text] [Related]
39. Pathology quiz case 2. Primary mucosal melanoma of the nasal cavity.
Calista D; Morri M; Riccioni L; Bassi M; Marchetti C
Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):475, 477-8. PubMed ID: 15096435
[No Abstract] [Full Text] [Related]
40. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
